Tibet Weixinkang Medicine Co Ltd (603676) - Total Liabilities
Based on the latest financial reports, Tibet Weixinkang Medicine Co Ltd (603676) has total liabilities worth CN¥423.85 Million CNY (≈ $62.02 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Tibet Weixinkang Medicine Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Tibet Weixinkang Medicine Co Ltd - Total Liabilities Trend (2013–2025)
This chart illustrates how Tibet Weixinkang Medicine Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 603676 current and non-current assets.
Tibet Weixinkang Medicine Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tibet Weixinkang Medicine Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Great Lakes Dredge & Dock
NASDAQ:GLDD
|
USA | $765.63 Million |
|
Medikaloka Hermina PT
JK:HEAL
|
Indonesia | Rp4.91 Trillion |
|
Sporton International
TWO:6146
|
Taiwan | NT$1.76 Billion |
|
Fastighetsbolaget Emilshus AB
ST:EMIL-B
|
Sweden | Skr7.53 Billion |
|
Concord Securities Co Ltd
TWO:6016
|
Taiwan | NT$46.96 Billion |
|
Universal Cement Corp
TW:1104
|
Taiwan | NT$5.62 Billion |
|
Guilin Tourism Corp Ltd
SHE:000978
|
China | CN¥1.17 Billion |
|
Guangzhou Grandbuy Co Ltd
SHE:002187
|
China | CN¥3.16 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Tibet Weixinkang Medicine Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Tibet Weixinkang Medicine Co Ltd to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tibet Weixinkang Medicine Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tibet Weixinkang Medicine Co Ltd (2013–2025)
The table below shows the annual total liabilities of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥390.49 Million ≈ $57.14 Million |
-16.61% |
| 2024-12-31 | CN¥468.24 Million ≈ $68.52 Million |
+7.26% |
| 2023-12-31 | CN¥436.55 Million ≈ $63.88 Million |
-1.71% |
| 2022-12-31 | CN¥444.13 Million ≈ $64.99 Million |
+3.70% |
| 2021-12-31 | CN¥428.31 Million ≈ $62.67 Million |
+13.65% |
| 2020-12-31 | CN¥376.85 Million ≈ $55.15 Million |
+0.61% |
| 2019-12-31 | CN¥374.56 Million ≈ $54.81 Million |
+11.04% |
| 2018-12-31 | CN¥337.33 Million ≈ $49.36 Million |
+112.71% |
| 2017-12-31 | CN¥158.58 Million ≈ $23.21 Million |
+70.64% |
| 2016-12-31 | CN¥92.94 Million ≈ $13.60 Million |
-12.18% |
| 2015-12-31 | CN¥105.82 Million ≈ $15.49 Million |
+37.27% |
| 2014-12-31 | CN¥77.09 Million ≈ $11.28 Million |
+25.31% |
| 2013-12-31 | CN¥61.52 Million ≈ $9.00 Million |
-- |
About Tibet Weixinkang Medicine Co Ltd
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. It offers APIs; multivitamins and pediatric multivitamins for injections; concentrate of trace elements solution for infusion; compound and pediatric compound amino acid injections; iron sucrose, multiple electrolytes, potassium aspartate and magnesium… Read more